Background:
Poor water soluble compounds are difficult to develop as drug products using conventional
formulation techniques.
Objective:
In the present study, the potential of Eudragit RS-100 nanosuspension as a new vehicle for the improvement of
the delivery of drugs to the intraocular level was investigated.
Methods :
Solvent evaporation technique has been employed for nanosuspension preparation. Surfactant concentration and
drug to polymer ratio has been optimized using 32
factorial design to achieve desired particle size, entrapment efficiency
and percent permeation responses as dependent variables. All the formulations were characterized for particle size, zeta
potential, polydispersity index (PDI), Fourier transform infrared spectroscopy (FTIR), Differential
scanning calorimetery (DSC), X-ray diffraction (XRD) analysis, viscosity, antifungal study and Transmission electron
microscopy (TEM). Secondly, itraconazole eye drop was prepared by using sulfobuty ether-β-cyclodextrin and
comparatively studied its antifungal efficacy.
Results:
The nanosuspension had a particle size range of 332.7-779.2nm, zeta potential +0.609-16.3, entrapment
efficiency 61.32±1.36%-76.34±2.04%. Ex vitro corneal permeability study showed that optimized Itraconazole
nanosuspension produced higher permeation as compared to market formulation and Itraconazole eye drop. Moreover,
optimized nanosuspension was found as more active against Candida albicans & Aspergillus flavus compared to market
formulation and Itraconazole eye drop.
Conclusion:
The nanosuspension approach could be an ideal, promising approach to increases the solubility and
dissolution of Itraconazole.